Home › Blogs › daniel's blog

Phytopharm sees FDA submission for weight product Hoodia in late 2009

user warning: Table './md_sites_daniel_hoodialat/accesslog' is marked as crashed and should be repaired query: INSERT INTO accesslog (title, path, url, hostname, uid, sid, timer, timestamp) values('Phytopharm initiates Stage 3 of its Hoodia extract deal with Unilever', 'node/358', '', '38.107.179.242', 0, 'vf83tench7nc10rs19bm47jnv2', 939, 1337291668) in /home/server/minimald/drupal/versions/drupal-5.1/includes/database.mysql.inc on line 172.
Tue, 07/15/2008 - 09:58 — daniel

Phytopharm sees FDA submission for weight product Hoodia in late 2009 - Phytopharm Plc. said it expects Hoodia extract, its weight management product partnered with Anglo-Dutch giant Unilever, to progress towards submission to the U.S. Food and Drug Administration by late in 2009.

In an interim management statement, the company which finds drug candidates in natural Chinese medicine, said it is looking at other territories for its canine
skin health product Phytopica.

Cogane, used to treat Parkinson's and Myogane for lateral sclerosis, continue to make good progress, with Cogane now benefiting from the financial support from The Michael J. Fox Foundation, the company said.

Chief executive Daryl Rees said, 'With a strengthened balance sheet we look forward to reporting on continued progress with the products in our pipeline in the second half of 2008.'

Cash and cash equivalents as at March 31 were 8.80 million pounds, Phytopharm added. TFN.newsdesk@thomson.com yos/ran/ajb
Source. Hemscott [Hoodia Information and News]

urchinTracker();